ArticleCureus2026
Soft Tissue Ewing Sarcoma in a Child: A Rare Localization.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ewing sarcoma (ES) is a primitive neuroectodermal tumor usually located in the bones. The soft tissue as a primary localisation of ES is extremely rare. A few cases have been reported in the literature; the most affected areas are the head, trunk, neck, upper and lower limbs, or even multiple lesions. It is most often a painful and mobile subcutaneous swelling with a soft consistency; metastasis is very rare. Differential diagnosis is made with other small round cell neoplasms. Therapy for ES includes chemotherapy, radiation therapy, and surgery. In this paper, we discuss the findings of a soft tissue ewing sarcoma (STES) located in the right arm in a 14-year-old boy successfully treated in our department of pediatric surgery. The follow-up did not show any sign of recurrence after 24 months.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.